Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;49(4):530-5.
doi: 10.1007/s00120-009-2179-x.

[Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation]

[Article in German]
Affiliations

[Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation]

[Article in German]
J Pannek et al. Urologe A. 2010 Apr.

Abstract

Antimuscarinic drugs are regarded as the standard treatment of detrusor overactivity (DO). However, side effects and lack of efficacy cause patients to discontinue long-term therapy. We evaluated the clinical efficacy of functional external electrostimulation (FES) as "second-line" therapy in patients with symptomatic idiopathic or neurogenic DO.In a retrospective study, 52 patients (38 women and 14 men) were evaluated at least 1 year after FES. Eighteen patients (32.7%) regarded FES as successful. No change occurred in 34 patients (65.4%) and 1 patient reported worsening of symptoms. Treatment success lasted for 13.2 months. In successfully treated patients, voiding frequency was significantly reduced from 13.3/24 h to 6.1/24 h under FES and to 6.75/24 h at follow-up. FES is a clinically useful, well-tolerated, conservative second-line treatment option after failed antimuscarinic treatment in patients with idiopathic or neurogenic DO.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Urology. 2006 Nov;68(5):999-1004 - PubMed
    1. Acta Obstet Gynecol Scand Suppl. 1998;168:12-5 - PubMed
    1. JAMA. 2002 Nov 13;288(18):2293-9 - PubMed
    1. Am J Obstet Gynecol. 1997 Sep;177(3):536-40 - PubMed
    1. JAMA. 1998 Dec 16;280(23):1995-2000 - PubMed

Publication types

Substances

LinkOut - more resources